Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome.
作者信息
Rao Indu R, Pinnamaneni Siva Tez, Ranjana Minz, Ritambhra Nada, Vivek Kumar, Manish Rathi, Kohli Harbir S, Jha Vivekanand V, Gupta Krishan, Raja Ramachandran
机构信息
Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
出版信息
Nephrology (Carlton). 2017 Sep;22(9):731-732. doi: 10.1111/nep.12924.
PMID:28792127
Abstract
摘要
Zotero 插件